[{"indications": "Indications\u00a0hypertension (including reduction of stroke risk in hypertension\r\nwith left ventricular hypertrophy); chronic heart failure when ACE\r\ninhibitors are unsuitable or contra-indicated; diabetic nephropathy\r\nin type 2 diabetes mellitus (see also notes above)", "name": "LOSARTAN POTASSIUM", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.5 Hypertension and heart failure", "2.5.5 Drugs affecting the renin-angiotensin system", "2.5.5.2 Angiotensin-II receptor antagonists"], "cautions": "Cautions\u00a0\n(From 2.5.5.2 Angiotensin-II receptor antagonists: British National Formulary)\nCautions\u00a0Angiotensin-II receptor antagonists should be used with caution in renal artery stenosis (see also Renal Effects under ACE Inhibitors, section 2.5.5.1). Monitoring of plasma-potassium concentration is advised, particularly in the elderly and in patients with renal impairment; lower initial doses may be appropriate in these patients. Angiotensin-II receptor antagonists should be used with caution in aortic or mitral valve stenosis and in hypertrophic cardiomyopathy. Those with primary aldosteronism, and Afro-Caribbean patients (particularly those with left ventricular hypertrophy), may not benefit from an angiotensin-II receptor antagonist. Interactions: Appendix 1 (angiotensin-II receptor antagonists).; severe heart failure", "side-effects": "Side-effects\u00a0see notes above; vertigo; less commonly gastro-intestinal disturbances, angina, palpitation, oedema, dyspnoea,\r\nheadache, sleep disorders, malaise, urticaria, pruritus, rash; rarely hepatitis, atrial fibrillation, cerebrovascular accident,\r\nsyncope, paraesthesia; also reported pancreatitis, anaphylaxis, cough,\r\ndepression, erectile dysfunction, anaemia, thrombocytopenia, hyponatraemia,\r\narthralgia, myalgia, renal impairment, rhabdomyolysis, tinnitus, photosensitivity,\r\nand vasculitis (including Henoch-Sch\u00f6nlein purpura)", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/27526.htm", "doses": ["Hypertension, diabetic nephropathy in type 2 diabetes\r\nmellitus, usually 50\u00a0mg once daily (intravascular volume depletion,\r\ninitially 25\u00a0mg once daily); if necessary increased after several\r\nweeks to 100\u00a0mg once daily; elderly over 75 years initially 25\u00a0mg daily", "Chronic heart failure, initially 12.5\u00a0mg once daily, increased\r\nat weekly intervals to max. 150\u00a0mg once daily if tolerated"], "pregnancy": "Pregnancy\u00a0\n(From 2.5.5.2 Angiotensin-II receptor antagonists: British National Formulary)\nPregnancy\u00a0Angiotensin-II receptor antagonists should be avoided in pregnancy unless essential. They may adversely affect fetal and neonatal blood pressure control and renal function; skull defects and oligohydramnios have also been reported."}, {"indications": "Indications\u00a0hypertension (including reduction of stroke risk in hypertension\r\nwith left ventricular hypertrophy); chronic heart failure when ACE\r\ninhibitors are unsuitable or contra-indicated; diabetic nephropathy\r\nin type 2 diabetes mellitus (see also notes above)", "name": "LOSARTAN POTASSIUM With diuretic", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.5 Hypertension and heart failure", "2.5.5 Drugs affecting the renin-angiotensin system", "2.5.5.2 Angiotensin-II receptor antagonists", "LOSARTAN POTASSIUM", "With diuretic"], "cautions": "Cautions\u00a0\n(From 2.5.5.2 Angiotensin-II receptor antagonists: British National Formulary)\nCautions\u00a0Angiotensin-II receptor antagonists should be used with caution in renal artery stenosis (see also Renal Effects under ACE Inhibitors, section 2.5.5.1). Monitoring of plasma-potassium concentration is advised, particularly in the elderly and in patients with renal impairment; lower initial doses may be appropriate in these patients. Angiotensin-II receptor antagonists should be used with caution in aortic or mitral valve stenosis and in hypertrophic cardiomyopathy. Those with primary aldosteronism, and Afro-Caribbean patients (particularly those with left ventricular hypertrophy), may not benefit from an angiotensin-II receptor antagonist. Interactions: Appendix 1 (angiotensin-II receptor antagonists).; severe heart failure", "side-effects": "Side-effects\u00a0see notes above; vertigo; less commonly gastro-intestinal disturbances, angina, palpitation, oedema, dyspnoea,\r\nheadache, sleep disorders, malaise, urticaria, pruritus, rash; rarely hepatitis, atrial fibrillation, cerebrovascular accident,\r\nsyncope, paraesthesia; also reported pancreatitis, anaphylaxis, cough,\r\ndepression, erectile dysfunction, anaemia, thrombocytopenia, hyponatraemia,\r\narthralgia, myalgia, renal impairment, rhabdomyolysis, tinnitus, photosensitivity,\r\nand vasculitis (including Henoch-Sch\u00f6nlein purpura)", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/215497.htm", "doses": ["Hypertension, diabetic nephropathy in type 2 diabetes\r\nmellitus, usually 50\u00a0mg once daily (intravascular volume depletion,\r\ninitially 25\u00a0mg once daily); if necessary increased after several\r\nweeks to 100\u00a0mg once daily; elderly over 75 years initially 25\u00a0mg daily", "Chronic heart failure, initially 12.5\u00a0mg once daily, increased\r\nat weekly intervals to max. 150\u00a0mg once daily if tolerated", "Name[Losartan potassium with hydrochlorothiazide (Non-proprietary) ] Tablets, losartan potassium 100\u00a0mg,\r\nhydrochlorothiazide 25\u00a0mg, net price 28\u2013tab pack = \u00a33.81"], "pregnancy": "Pregnancy\u00a0\n(From 2.5.5.2 Angiotensin-II receptor antagonists: British National Formulary)\nPregnancy\u00a0Angiotensin-II receptor antagonists should be avoided in pregnancy unless essential. They may adversely affect fetal and neonatal blood pressure control and renal function; skull defects and oligohydramnios have also been reported."}]